The Senior Leadership is responsible for the overall planning and operations of the programs and activities of the Robert H. Lurie Comprehensive Cancer Center. The Senior Leadership is comprised of the Director, Deputy Director and eight Associate Directors and has undergone a number of changes during the current project period. Dr. Steven Rosen has continued as Director since 1989. Recruitment for the position of Deputy Director, proposed and approved at the time of the last site visit, was successfully completed in May, 2002 with the recruitment of Leonidas Platanias, MD, PhD, from the University of Illinois. Leadership of the three research divisions has changed during this period as well. In August, 2002, Teresa Woodruff, PhD assumed the position of Associate Director for Basic Sciences Research replacing Dr. J. Douglas Engel who left Northwestern. In September, 2004, Susan Gapstur, PhD, assumed the position of Associate Director for Cancer Prevention and Control Research, replacing Dr. Philip Greenland. This change reflected recommendations of the last site visit team for more focused expertise in this division. In March, 2006, Jonathan Licht, MD, replaced Dr. Leo Gordon as Chief of Hematology/Oncology and was appointed simultaneously as Associate Director for Clinical Sciences Research. The Associate Director for Education, Mary Kathleen Rundell, PhD, and Associate Director for Administration, Mr. Timothy Volpe remain unchanged. In addition to the five major operating divisions of the Cancer Center headed by these Associate Directors, three new Associate Director positions have been added. Based on recommendations of the last site visit team and input from Internal and External Advisory Boards for increased emphasis on translational research, the position of Associate Director for Translational Research was established and Jill C. Pelling, PhD was recruited in August, 2004 from the University of Kansas Medical Center. In response to significant growth, two other Associate Director positions were established in April, 2003. Al B. Benson, III, MD serves as Associate Director for Clinical Investigations overseeing the Center's clinical trials affiliate network, and Julian Schink, MD serves as Associate Director for Clinical Affairs, directing the Clinical Cancer Center. CCSG support is not requested for the Associate Directors for Clinical Investigations and Clinical Affairs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA060553-17
Application #
8135577
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
17
Fiscal Year
2010
Total Cost
$576,656
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Nahum-Shani, Inbal; Smith, Shawna N; Spring, Bonnie J et al. (2018) Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support. Ann Behav Med 52:446-462
Kang, Hong-Jun; Song, Ha Yong; Ahmed, Mohamed A et al. (2018) NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity. Free Radic Biol Med 126:358-371
Long, Alan; Dominguez, Donye; Qin, Lei et al. (2018) Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression. J Immunol 201:3456-3464
Lewis, Phillip L; Su, Jimmy; Yan, Ming et al. (2018) Complex bile duct network formation within liver decellularized extracellular matrix hydrogels. Sci Rep 8:12220
Hong, Bong Jin; Iscen, Aysenur; Chipre, Anthony J et al. (2018) Highly Stable, Ultrasmall Polymer-Grafted Nanobins (usPGNs) with Stimuli-Responsive Capability. J Phys Chem Lett 9:1133-1139
Smith, Erica D; Garza-Gongora, Arturo G; MacQuarrie, Kyle L et al. (2018) Interstitial telomeric loops and implications of the interaction between TRF2 and lamin A/C. Differentiation 102:19-26
Hsiao, Hsi-Min; Fernandez, Ramiro; Tanaka, Satona et al. (2018) Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1?. J Clin Invest 128:2833-2847
Mehta, Amol; Awah, Chidiebere U; Sonabend, Adam M (2018) Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy. Front Neurol 9:459
Brown, Jessica H; Das, Prativa; DiVito, Michael D et al. (2018) Nanofibrous PLGA electrospun scaffolds modified with type I collagen influence hepatocyte function and support viability in vitro. Acta Biomater 73:217-227
Ntai, Ioanna; Fornelli, Luca; DeHart, Caroline J et al. (2018) Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk. Proc Natl Acad Sci U S A 115:4140-4145

Showing the most recent 10 out of 1972 publications